Skip to main content
. 2021 Apr 22;30(4):385–394. doi: 10.1159/000516776

Table 1.

Clinical performance characteristics of LFA in serum to detect SARS-CoV-2 antibodies

IgM and/or IgG MedTest EcoTest Camtech Wondfo
value 95% CI value 95% CI value 95% CI value 95% CI
Group PCR+/PCR–
 TP 69 67 76 71
 Sensitivity, % 84.15 74.42; 91.28 81.71 71.63; 89.38 92.68 84.75; 97.27 86.59 77.26; 93.11
 Specificity, % 100.00 90.51; 100.00 78.38 61.79; 90.17 78.38 61.79; 90.17 100.00 90.51; 100.00
 LR (+) 32.50 4.68; 225.50 3.78 2.03; 7.04 4.29 2.31; 7.94 33.43 4.82; 231.85
 LR (−) 0.16 0.10; 0.26 0.23 0.14; 0.38 0.09 0.04; 0.21 0.13 0.08; 0.23
 DOR 203.00 46.80; 867.00 16.43 14.5; 18.53 47.67 57.75; 37.81 257.15 60.25; 1,008
 Youden's index 0.84 0.65; 0.91 0.60 0.33; 0.80 0.71 0.47; 0.87 0.87 0.68; 0.93
 CUI+ 0.84 0.77; 0.92 0.73 0.64; 0.83 0.84 0.77; 0.91 0.87 0.80; 0.94
 CUI– 0.74 0.66; 0.82 0.52 0.40; 0.63 0.65 0.54; 0.76 0.77 0.69; 0.85
 PPV, % 100.00 89.33 81.81; 93.98 90.48 83.68; 94.62 100.00
 NPV, % 74.00 63.35; 82.41 65.91 54.28; 75.90 82.86 68.71; 91.41 77.08 66.00; 85.36
 Accuracy, % 89.08 82.04; 94.05 80.67 72.42; 87.34 88.24 81.05; 93.42 90.76 84.06; 95.29
 MCC 0.79 0.57 0.72 0.82
Group PCR+
 TP 68 65 69 69
 Sensitivity, % 97.14 90.06; 99.65 92.86 84.11; 97.64 98.57 92.30; 99.96 98.57 92.30; 99.96
 Specificity, % 100.00 90.51; 100.00 78.38 61.79; 90.17 78.38 61.79; 90.17 100.00 90.51; 100.00
 LR (+) 37.37 5.40; 258.87 4.29 2.32; 7.96 4.56 2.47; 8.43 37.92 5.48; 262.56
 LR (−) 0.03 0.01; 0.11 0.09 0.04; 0.22 0.02 0.00; 0.13 0.01 0.00; 0.10
 DOR 1,245 540; 2,353 47.66 58.00; 36.18 228 0.00; 64.85 3,792 0.00; 2,625
 Youden's index 0.97 0.81; 1.00 0.71 0.46; 0.88 0.77 0.54; 0.90 0.99 0.83; 1.00
 CUI+ 0.97 0.94; 1.00 0.83 0.75; 0.91 0.88 0.82; 0.95 0.99 0.96; 1.00
 CUI– 0.95 0.91; 0.99 0.67 0.56; 0.78 0.75 0.66; 0.86 0.97 0.94; 1.00
 PPV, % 100.00 89.04 81.43; 93.77 89.61 82.35; 94.10 100.00
 NPV, % 94.87 82.52; 98.64 85.29 71.02; 93.21 96.67 80.44; 99.51 97.37 84.09; 99.62
 Accuracy, % 98.13 93.41; 99.77 87.85 80.12; 93.37 91.59 84.63; 96.08 99.07 94.90; 99.98
 MCC 0.96 0.73 0.81 0.98
Group PCR–
 TP 01 02 07 02
 Sensitivity, % 8.33 0.21; 38.48 16.67 2.09; 48.41 58.33 27.67; 84.83 16.67 2.09; 48.41
 Specificity, % 100.00 90.51; 100.00 78.38 61.79; 90.17 78.38 61.79; 90.17 100.00 90.51; 100.00
 LR (+) 5.57 0.55; 56.78 0.77 0.19; 3.14 2.70 1.24; 5.87 8.36 0.95; 73.88
 LR (−) 0.92 0.77; 1.09 1.06 0.78; 1.44 0.53 0.27; 1.06 0.83 0.65; 1.07
 DOR 6.05 0.71; 52.02 0.73 0.24; 2.18 5.09 4.59; 5.54 10.07 1.46; 69.05
 Youden's index 0.08 −0.09; 0.39 −0.05 −0.36; 0.39 0.37 −0.11; 0.75 0.17 −0.07; 0.48
 CUI+ 0.08 0.00; 0.55 0.03 0.00; 0.31 0.27 0.00; 0.60 0.17 0.00; 0.61
 CUI– 0.77 0.69; 0.84 0.58 0.47; 0.70 0.67 0.56; 0.78 0.79 0.71; 0.87
 PPV, % 100.00 20.00 5.77; 50.49 46.67 28.67; 65.57 100.00
 NPV, % 77.08 73.93; 79.96 74.36 68.14; 79.72 85.29 74.41; 92.04 78.72 74.18; 82.65
 Accuracy, % 77.55 63.38; 88.23 63.27 48.29; 76.58 73.47 58.92; 85.05 79.59 65.66; 89.76
 MCC 0.25 −0.05 0.34 0.36

LFA, lateral flow immunochromatographic assay; TP, true positive; PPV, positive predictive value; NPV, negative predictive value; LR, likelihood ratio; DOR, diagnostic odds ratio (the higher the DOR value, the better the test); CUI, clinical utility index; MCC, Matthews correlation coefficient.